Targeting Long Non-coding RNA to Therapeutically Regulate Gene Expression in Cancer

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Long-chain non-coding RNAs (lncRNAs) are RNA molecules >200 nucleotides that do not encode proteins.
• lncRNAs regulate gene expression at transcriptional and post-transcriptional levels, influencing cell growth, differentiation, and apoptosis.
• Aberrant lncRNA expression is increasingly associated with tumor development and progression.

Purpose of the Study:

• To review the molecular mechanisms of lncRNAs in tumor development.
• To explore the clinical application prospects of lncRNAs as cancer biomarkers and therapeutic targets.

Main Methods:

• Literature review of studies on lncRNA function and cancer.
• Analysis of sequencing data implicating non-coding region mutations in tumorigenesis.
• Examination of lncRNA roles in gene expression regulation.

Main Results:

• lncRNAs are crucial regulators of cellular processes relevant to cancer.
• Mutations in non-coding regions, including lncRNAs, may drive tumor initiation and progression.
• lncRNAs show promise as effective biomarkers for tumor diagnosis.

Conclusions:

• Understanding lncRNA mechanisms is vital for clarifying tumor development.
• lncRNAs represent promising novel targets for cancer diagnosis and treatment.
• Further research into lncRNAs can advance precision oncology.